Methadone and buprenorphine-related deaths among people prescribed and not prescribed Opioid Agonist Therapy during the COVID-19 pandemic in England

被引:20
作者
Aldabergenov, D. [1 ]
Reynolds, L. [1 ]
Scott, J. [2 ]
Kelleher, M. J. [3 ,4 ]
Strang, J. [3 ,4 ]
Copeland, C. S. [1 ]
Kalk, N. J. [3 ,4 ,5 ]
机构
[1] Kings Coll London, Inst Pharmaceut Sci, Ctr Pharmaceut Med Res, London, England
[2] Univ Bath, Dept Pharm & Pharmacol, Bath, England
[3] South London & Maudsley NHS Fdn Trust, London, England
[4] Kings Coll London, Inst Psychol Psychiat & Neurosci, Natl Addict Ctr, London, England
[5] IOPPN, Kings Coll London, Natl Addict Ctr, 4 Windsor Walk, London SE5 8BB, England
关键词
Methadone; Buprenorphine; Opioid agonist therapy; COVID-19; Drug-related death; Mortality; RISK; OVERDOSE;
D O I
10.1016/j.drugpo.2022.103877
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Background: The coronavirus pandemic resulted in many changes which had the potential to impact mortality related to opioid agonist therapy (OAT; methadone, buprenorphine), including changes in the prescribing and dispensing of OAT and patterns of drug availability and use. We aimed to assess the impact of the first lock-down (initiated March 23rd 2020) on methadone- and buprenorphine-related deaths in England in people both prescribed and not prescribed OAT using data from the National Programme on Substance Abuse Deaths. Methods: This was a retrospective post-mortem toxicology study of OAT-related deaths which occurred in the 3-month period March 23rd to June 22nd in the years 2016-2020. Provisional data regarding numbers accessing treatment for opioid use disorder was provided by the National Drug Treatment Monitoring System. Results: We found a 64% increase in methadone-related deaths in March to June 2020 compared to March to June 2019 (2019 n = 96; 2020 projected n = 157). There were increases in the mortality rate of both in-treatment decedents (22% increase; 2019 n = 45; an exponential smoothing model of the 2016-19 trend [alpha. = 0.5] predicted 44 deaths in 2020, 55 were reported) and decedents not prescribed methadone (74% increase; 2019 n = 46; 2016-19 trend predicted 43 deaths in 2020, 80 were reported). There was no increase in buprenorphine-related deaths (2019 n = 9/529; 2020 n = 11/566). There were no changes in the numbers of deaths where other opioids or multiple substances were detected, or in methadone levels detected. Numbers of people accessing treatment for opioid use disorder in 2020 did not decrease relative to previous years (p > 0.05). Conclusions: Methadone-related deaths in non-prescribed individuals, but not prescribed individuals, increased considerably above the annual trend forecast for 2020 during the first COVID-19 lockdown in England. Further studies are thus needed to understand this difference.
引用
收藏
页数:8
相关论文
共 53 条
[1]   The impact of relaxation of methadone take-home protocols on treatment outcomes in the COVID-19 era [J].
Amram, Ofer ;
Amiri, Solmaz ;
Panwala, Victoria ;
Lutz, Robert ;
Joudrey, Paul J. ;
Socias, Eugenia .
AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE, 2021, 47 (06) :722-729
[2]   Availability and use of non-prescribed buprenorphine-naloxone in a Canadian setting, 2014-2020 [J].
Bach, Paxton ;
Bawa, Misha ;
Grant, Cameron ;
Milloy, M. J. ;
Hayashi, Kanna .
INTERNATIONAL JOURNAL OF DRUG POLICY, 2022, 101
[3]   Did drug use increase following COVID-19 relaxation of methadone take-out regulations? 2020 was a complicated year [J].
Bart, Gavin ;
Wastvedt, Solvejg ;
Hodges, James S. ;
Rosenthal, Rebecca .
JOURNAL OF SUBSTANCE ABUSE TREATMENT, 2022, 133
[4]  
Baselt Randal., 2011, Disposition of Toxic Drugs and Chemicals in Man, VNinth
[5]   Unintentional drug overdose: Is more frequent use of non-prescribed buprenorphine associated with lower risk of overdose? [J].
Carlson, Robert G. ;
Daniulaityte, Raminta ;
Silverstein, Sydney M. ;
Nahhas, Ramzi W. ;
Martins, Silvia S. .
INTERNATIONAL JOURNAL OF DRUG POLICY, 2020, 79
[6]   Changes in Buprenorphine and Methadone Supplies in the US During the COVID-19 Pandemic [J].
Chen, Annie Y. ;
Powell, David ;
Stein, Bradley D. .
JAMA NETWORK OPEN, 2022, 5 (07) :e2223708
[7]  
CLARIDGE H, 2015, DRUG RELATED DEATHS
[8]   Abuse liability of prescription opioids compared to heroin in morphine-maintained heroin abusers [J].
Comer, Sandra D. ;
Sullivan, Maria A. ;
Whittington, Robert A. ;
Vosburg, Suzanne K. ;
Kowalczyk, William J. .
NEUROPSYCHOPHARMACOLOGY, 2008, 33 (05) :1179-1191
[9]   Recreational ketamine-related deaths notified to the National Programme on Substance Abuse Deaths, England, 1997-2019 [J].
Corkery, John Martin ;
Hung, Wan-Chu ;
Claridge, Hugh ;
Goodair, Christine ;
Copeland, Caroline S. ;
Schifano, Fabrizio .
JOURNAL OF PSYCHOPHARMACOLOGY, 2021, 35 (11) :1324-1348
[10]  
EBM DataLab University of Oxford, OPENPRESCRIBING NET